- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT05267665
PTSD 치료에 가족 참여(FIT-PTSD): 결과, 유지 및 참여를 향상시키기 위한 간단하고 실행 가능한 방법
Although effective treatments for PTSD exist, high rates of treatment dropout and sub-optimal response rates remain common. Incorporating family members in treatment represents one avenue for improving outcomes and providing Veteran-centered care, and surveys of Veterans in outpatient VA PTSD care indicate that 80% desire family involvement. The VA has invested many years and millions of dollars on the dissemination of Cognitive Processing Therapy (CPT) and Prolonged Exposure (PE) for PTSD. A family-based intervention that complements these two first-line treatments would capitalize on existing treatment infrastructure while also potentially boosting outcomes and retention.
Preliminary testing of the proposed Brief Family Intervention (BFI) resulted in 50% less dropout from CPT/PE among Veterans whose family members received the BFI. There was also a large impact on PTSD symptoms at 16 weeks (d = 1.12) in favor of the BFI group. The goal of this study is to test the effectiveness of the BFI among a fully-powered sample. One hundred Veteran-family member dyads (n = 200) will be recruited. Veterans will be beginning a course of usual-care CPT or PE at one of two VA sites. Family members will be randomized to receive or not receive the BFI, a two-session psychoeducational and skills-based protocol. PTSD symptom severity and treatment retention will be the primary outcomes. Assessments will be conducted by independent evaluators at baseline, 6-, 12-, 18-, and 26-weeks. Veterans whose family members receive the BFI are expected to have lower dropout and a greater rate of change in their PTSD symptoms compared to Veterans whose family members do not receive the BFI. If the BFI is found to increase the effectiveness of and retention in CPT/PE, it will be a highly appealing option for incorporating families into Veterans' PTSD care.
연구 개요
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Johanna Thompson-Hollands, PhD
- 전화번호: (857) 364-2067
- 이메일: Johanna.Thompson-Hollands@va.gov
연구 연락처 백업
- 이름: Cameron Busser, BA
- 전화번호: (857) 364-4143
- 이메일: cameron.busser@va.gov
연구 장소
-
-
Massachusetts
-
Boston, Massachusetts, 미국, 02130-4817
- 모병
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
-
연락하다:
- Johanna Thompson-Hollands, PhD
- 전화번호: (857) 364-2067
- 이메일: Johanna.Thompson-Hollands@va.gov
-
수석 연구원:
- Johanna Thompson-Hollands, PhD
-
연락하다:
- Cameron Busser, BA
- 전화번호: (857) 364-4143
- 이메일: cameron.busser@va.gov
-
-
North Carolina
-
Durham, North Carolina, 미국, 27705-3875
- 모병
- Durham VA Medical Center, Durham, NC
-
연락하다:
- Nicole Pukay-Martin, PhD
- 전화번호: 17-7548 919-286-0411
- 이메일: nicole.pukay-martin@va.gov
-
-
Ohio
-
Cincinnati, Ohio, 미국, 45220
- 모병
- Cincinnati VA Medical Center, Cincinnati, OH
-
연락하다:
- Nicole Pukay-Martin, PhD
- 전화번호: 3251 513-861-3100
- 이메일: nicole.pukay-martin@va.gov
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
Inclusion criteria for Veterans will include:
-
a current DSM-5 diagnosis of PTSD
-
Veteran status
-
willing to have a family member involved in the study
-
has recently begun or is currently initiating individual CPT or PE (completed no more than 3 sessions of the protocol at the time of the baseline assessment)
- If taking psychotropic medication, the Veteran must be on a stable dose for at least 30 days.
Inclusion criteria for family members will include:
- age 18 or older, family member of the Veteran (significant other, parent, adult child, sibling, etc.)
- currently having frequent contact with the Veteran (three or more times per week)
Exclusion Criteria:
Exclusion criteria for Veterans will include:
- current engagement in couple/family treatment with the identified family member participant
- current severe substance use disorder (mild/moderate use disorders will not be excluded; any level of nicotine or caffeine use disorder accepted)
- current psychosis or unstable bipolar disorder diagnosis
- high suicidal risk
- significant cognitive impairment
Exclusion criteria for family members will include:
- same as listed for Veterans. Additionally
- family members will NOT be permitted to participate if they meet criteria for current PTSD
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: BFI
Family members in this arm receive the 2-session BFI intervention. |
A 2-session psychoeducational and skills-based family intervention. |
|
간섭 없음: No BFI
Family members in this arm do not receive the BFI sessions |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)
기간: Week 26
|
Severity of PTSD symptoms. Minimum score is 0 (best possible, no symptoms) and maximum score is 80 (worst possible, highest symptoms). |
Week 26
|
|
Adequate treatment dose
기간: Week 26
|
Categorical evaluation of whether the participant received 8 or more on-protocol sessions of CPT or PE during their 26-week study participation period. Possible scores are 0 (meaning <8 sessions received; this is considered a poor outcome) or 1 (meaning 8 or more sessions received; this is considered a good outcome). |
Week 26
|
|
Treatment dropout
기간: Week 26
|
Categorical evaluation of whether the participant dropped out of treatment early. Possible scores are 0 (meaning participant did not drop out of treatment early; this is considered a good outcome) or 1 (meaning participant did drop out of treatment early; this is considered a poor outcome). |
Week 26
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Homework compliance
기간: Week 26
|
Compliance with assigned homework during treatment. Minimum score is 0 (worst possible), maximum score is 150 (best possible). |
Week 26
|
|
Quality of Life Inventory (QOLI)
기간: Week 26
|
Quality of life. Minimum score is -6 (worst possible), maximum score is 6 (best possible). |
Week 26
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Johanna Thompson-Hollands, PhD, VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
키워드
추가 관련 MeSH 약관
기타 연구 ID 번호
- MHBP-005-21S
- 1I01CX002339-01A1 (미국 NIH 보조금/계약)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
An anonymous dataset that meets VA standards for disclosure to the public will be made available within 1 year of publication. Prior to distributions, a privacy officer at the primary site will certify that all datasets contain no PHI. The PI will create a de-identified dataset that will include all publication variables. To remove some PHI, loss of information may occur. The PI will replace any identifiable information with study-specific numbers. Data collected on age will be replaced by the PI with age categories to ensure data is in accordance with PHI requirements for people 85 years of age and older (if applicable).
IPD 공유 기간
An anonymous dataset that meets VA standards for disclosure to the public will be made available within 1 year of publication. The data will be made available until the data is destroyed according to the required timelines in the VA Record Control Schedule.
IPD 공유 액세스 기준
Individual requesting access to the data will be required to complete an adequate Data Use Agreement.
IPD 공유 지원 정보 유형
- 연구_프로토콜
- ICF
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
미국에서 제조되어 미국에서 수출되는 제품
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .